This HTML5 document contains 313 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://dx.doi.org/10.1155/2009/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33570512
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel videnskabelig artikel (udgivet 2009) vedecký článok 2009年论文 2009年論文 ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научна статия article scientifique (publié 2009) articol științific 2009年論文 artikulong pang-agham artykuł naukowy 2009年论文 სამეცნიერო სტატია artículo científico publicado en 2009 scienca artikolo سائنسی مضمون artigo científico (publicado na 2009) مقالهٔ علمی vitenskapelig artikkel 2009年论文 vetenskaplig artikel article scientific επιστημονικό άρθρο مقالة علمية mokslinis straipsnis vitskapeleg artikkel articolo scientifico 2009年論文 2009年论文 artigo científico (publicado na 2009) мақолаи илмӣ мақолаи илмӣ научни чланак vědecký článek naučni članak artículu científicu espublizáu en 2009 article científic artikull shkencor tieteellinen artikkeli scientific article 2009年論文 2009年论文 научная статья 2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված บทความทางวิทยาศาสตร์ 2009년 논문 2009年論文 2009 nî lūn-bûn наукова стаття, опублікована в грудні 2009 bài báo khoa học wissenschaftlicher Artikel tudományos cikk научни чланак 2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած teaduslik artikkel artigo científico bilimsel makale 2009年论文 2009年の論文 מאמר מדעי
p:P577
wds:Q33570512-F5FE09B9-A658-4E65-A88A-5048D3CB5892
wdt:P577
2009-12-29T00:00:00Z
p:P2860
wds:Q33570512-87F31D8D-7822-476C-BF63-F14CF1057A22 wds:Q33570512-7DFBB4A2-E9D2-4CCF-96F5-F5545FED8FCF wds:Q33570512-80A769BD-6029-4533-99CC-3B5BA3920F4B wds:Q33570512-850E8747-A2E3-4986-9966-C399DD38EFB1 wds:Q33570512-EEF8EC12-BBA1-4E3D-B0D4-03CE760D1C85 wds:Q33570512-E7FA9425-FC81-4556-9FE3-F550B6AAA4A4 wds:Q33570512-E95D537C-D1A5-4FD1-A00C-B7413694E22C wds:Q33570512-EABD6F47-BD6E-4CB6-A2B9-3B62679F9474 wds:Q33570512-F8741DB8-4DF5-487C-9E1B-ABE64AFCD095 wds:Q33570512-F903A5EF-516A-4DBF-A188-FF82884FC9A2 wds:Q33570512-4F14EA1D-C421-4043-9199-F0B62178FB52 wds:Q33570512-539BF3C2-75F0-44C4-A875-9C223846F468 wds:Q33570512-433E1568-CC90-423A-850F-3ADFE3F99735 wds:Q33570512-4379590F-FD8E-4DA0-BDBA-7A0BA9336A99 wds:Q33570512-474CF21A-B072-488C-925D-0EED8C5A45AC wds:Q33570512-6702D465-F581-4C13-94CD-F98D4803D004 wds:Q33570512-676231AC-C10C-44EE-A726-15AF6581D394 wds:Q33570512-695A9C7A-EA6E-4E93-BB48-B11F423E078E wds:Q33570512-642A8D68-5C8C-448B-ABF6-7737C410874F wds:Q33570512-658C1985-3A74-4073-B96F-14BFBE4D4F32 wds:Q33570512-3498DB4D-AA58-49B2-8752-DB781E6D0DEF wds:Q33570512-2B8A28D4-6870-4201-AD07-3C782243968F wds:Q33570512-2DDD3881-8545-4E9A-A948-8BAB7CB4E99C wds:Q33570512-3EC28034-3FA7-4C1E-941D-46568A36B8A8 wds:Q33570512-405C7EAB-700A-4909-B0D1-434D10BB1121 wds:Q33570512-3946C464-BB24-42FD-92BD-B37A3B86064E wds:Q33570512-3B825B3D-1BB6-4FDF-A6F9-3C69F7AFCE78 wds:Q33570512-3C3ECB0B-163C-4762-989B-5A4AFB099726 wds:Q33570512-3C9DD640-2C06-4437-BDD4-A76813001DF5 wds:Q33570512-031792D9-04B4-4B59-B660-D7C64259397B wds:Q33570512-06378B8A-983E-4F8A-9EF5-404A4247E9BF wds:Q33570512-0C07D5E6-3FFD-46B6-A1E3-8BC44148FFEC wds:Q33570512-14978225-A6E1-4862-A8D1-416719A011AD wds:Q33570512-23759577-7E42-4190-AFD7-CB86BE72F798 wds:Q33570512-26182792-E912-4FEF-95A8-515A699DAC68 wds:Q33570512-0CB92C0A-D429-44E8-B02D-D1005D36AAF8 wds:Q33570512-0D7A6A64-0C6F-4443-80DE-03438744015D wds:Q33570512-11DFF0F3-6EB1-45A9-87EA-FD3875D9A7C6 wds:Q33570512-12FE538C-5971-423B-B8B8-BD10A2E6D7D6 wds:Q33570512-D1B0D474-1359-4F96-AC49-202465DB5110 wds:Q33570512-D3D7E450-4285-4590-AC04-6D1D7EE8B76F wds:Q33570512-CB212042-B333-41ED-BADF-B82FE096F03F wds:Q33570512-CE182F20-E155-476F-AAD8-99208EF00AE9 wds:Q33570512-E21B0DD9-2478-4BCB-B793-4D2AAB3014EC wds:Q33570512-E2D2634F-41F1-48A6-A4C1-5BDA1352A7D9 wds:Q33570512-E44A57C9-3CF4-41E1-B23D-EBC01E110900 wds:Q33570512-D8584B42-2E25-4CF9-BE4C-6FB0CF0CDAB9 wds:Q33570512-E1493A6E-3787-4D48-9C48-01658B5A09D6 wds:Q33570512-E1C72821-8C99-4F1D-ACF6-45BFBFF6F966 wds:Q33570512-B2847A96-5D37-4769-AB22-436117D9304F wds:Q33570512-B3442C9F-F22F-4281-9071-EF49A1E5E981 wds:Q33570512-B3A8BF99-E8E7-4F86-9074-36DB3573FCA5 wds:Q33570512-B6A7A77D-ACCC-4CE6-B9F9-0B9880574AED wds:Q33570512-ABE1A786-0D3B-438D-81F5-F4E66ACC504F wds:Q33570512-AF0AE481-CEDF-4898-949B-E9B44967BC1A wds:Q33570512-AF8CD009-FE92-4D7F-AB27-4B70EAAE5556 wds:Q33570512-B1D57863-414E-4390-8659-E75B6BD50943 wds:Q33570512-BB22ACD9-7724-4D67-BAD5-753C6BE4D01C wds:Q33570512-C32A3054-7FD0-45FF-9830-182F552FB8EA wds:Q33570512-C34E03DA-F96F-4310-A76B-0615F42A7E8C wds:Q33570512-B76FF31F-5E26-4630-9CEA-02B0BB951F78 wds:Q33570512-B77172A1-9F24-4216-9A55-DF3C0DD5A913 wds:Q33570512-B86DD0DE-4522-4742-A557-DFB369FDAF32 wds:Q33570512-B932F489-5E57-4057-9721-3B096149E455 wds:Q33570512-9ABC57A1-D289-4732-A8B7-14D059A277E1 wds:Q33570512-88955578-66EF-4083-9903-AEB6AB59E229 wds:Q33570512-8EB9DE99-712B-463C-83D4-4815D3072E8D wds:Q33570512-90D32741-2A2E-45D9-B842-FABA808EE415 wds:Q33570512-91817AA3-281B-4E50-91EE-28CC997D939E wds:Q33570512-A22722AE-1659-44EF-8B11-FEF05C442A1A wds:Q33570512-A66F051A-47FD-4E66-AA28-76EC1CAEAA34 wds:Q33570512-A6F14267-3E35-497E-B3C8-4ADBC5364474 wds:Q33570512-AAEDC972-E0A9-46FA-9AF3-071D9022EEB5 wds:Q33570512-9CF7DBD5-4835-4699-9BDC-A9E35A102AFF wds:Q33570512-A1C5B5D7-5A71-4828-B344-7511AC9C13D2 wds:Q33570512-A1F39575-D605-466B-90FF-6AF6DE48480E wds:Q33570512-798DE115-50B4-4112-8E5C-B5C2EFB2D14E wds:Q33570512-7AA757D9-822C-4CAC-B692-33A974CFA4F8 wds:Q33570512-7CA72D42-78C7-449C-8972-583F998581EA wds:Q33570512-6C0015E1-9E98-421C-9CE3-E895440215C0 wds:Q33570512-6C021055-458E-411B-A034-F22101AA4438 wds:Q33570512-6EFE28B5-E83F-48F8-9BC0-BECF15D2B92B wds:Q33570512-7457BDC2-EA18-4BD4-9168-5141623793CA wds:Q33570512-86030FB0-3382-471D-A86F-A5D1AD91DC2D wds:Q33570512-868C0043-1453-4D4B-B703-FB8CBEF03EDA
wdt:P2860
wd:Q46686980 wd:Q79846920 wd:Q79227019 wd:Q37039593 wd:Q34533636 wd:Q77386062 wd:Q37193014 wd:Q36927335 wd:Q33178143 wd:Q46813416 wd:Q36175239 wd:Q53636339 wd:Q36178528 wd:Q82981693 wd:Q54588288 wd:Q46658577 wd:Q37086223 wd:Q81211241 wd:Q30679607 wd:Q37123817 wd:Q57618379 wd:Q34482745 wd:Q44795916 wd:Q40386013 wd:Q47637332 wd:Q27861059 wd:Q34557318 wd:Q53496208 wd:Q46597705 wd:Q34257800 wd:Q21563517 wd:Q35979732 wd:Q34471062 wd:Q37010568 wd:Q44849152 wd:Q37029666 wd:Q46069485 wd:Q74614675 wd:Q44260431 wd:Q30591228 wd:Q34134938 wd:Q73121452 wd:Q73483324 wd:Q42524527 wd:Q46833215 wd:Q34564091 wd:Q46362755 wd:Q73133036 wd:Q36670922 wd:Q51908580 wd:Q73937525 wd:Q38450854 wd:Q80751700 wd:Q55009967 wd:Q28266170 wd:Q37321772 wd:Q54677905 wd:Q78944717 wd:Q36138893 wd:Q38354253 wd:Q35730375 wd:Q44423483 wd:Q82676913 wd:Q27851502 wd:Q37112224 wd:Q73280172 wd:Q74649777 wd:Q46443613 wd:Q36992487 wd:Q36720868 wd:Q29619277 wd:Q46595210 wd:Q47741422 wd:Q56688854 wd:Q44674194 wd:Q27851409 wd:Q43732858 wd:Q37002363 wd:Q80557781 wd:Q40133869 wd:Q36500969 wd:Q36935109 wd:Q81950649 wd:Q46711573 wd:Q27851397
p:P2093
wds:Q33570512-7EFEC695-C639-4C5A-950E-160669ACC563 wds:Q33570512-9A9859D9-A709-4830-8FD3-9BB92D602071 wds:Q33570512-A0A058BD-D2F1-4D3C-831A-5575A0691CF1 wds:Q33570512-0A7350C5-C8ED-4D1B-84D6-AB81EE610559 wds:Q33570512-4AE5C050-604A-45C6-802B-3C9A4B150D4E wds:Q33570512-7D206E73-634B-41AE-A830-1CACB61D64B7
wdt:P2093
Despina Misailidou Demosthenis Skarlos Sophia Lambaki Eleni Athanassiou Samuel Murray Alexandros Lambropoulos
rdfs:label
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer
skos:prefLabel
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer
schema:name
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer
p:P50
wds:Q33570512-BB282349-C130-4EBD-8A4C-CA0415ED67AD wds:Q33570512-C77BD848-7D10-46D2-8093-8D42E82F22C0 wds:Q33570512-CEE46860-0CE9-451E-920D-2B0E3A5D017D wds:Q33570512-D1B5673C-EB90-4EB0-B22F-9E4002F597CE wds:Q33570512-8538F572-0957-4EF0-9D20-D18ED8662DAB wds:Q33570512-3E51243D-9297-412A-9A97-599A01975258 wds:Q33570512-56AD5F8B-B49E-458D-9139-8DF317050061 wds:Q33570512-4D353375-894D-4A16-B04E-3986E999EC22 wds:Q33570512-F73E6B81-3D1C-44C2-8276-E474282CAA07 wds:Q33570512-F507F526-72A8-4AFC-B7E7-2D441D3D8B27
wdt:P50
wd:Q116791801 wd:Q116791800 wd:Q95981969 wd:Q41163950 wd:Q56432880 wd:Q114420962 wd:Q56088813 wd:Q114420958 wd:Q114420983 wd:Q91842509
p:P1476
wds:Q33570512-F63BF735-7716-4C2C-BB04-84A561E76CEB
wdt:P1476
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer
p:P304
wds:Q33570512-333550E1-50EE-4207-AEE0-23B1DC6AF3C3
wdt:P304
305908
p:P31
wds:Q33570512-5D5FBBB9-D1F4-4EAA-9938-866D781926B9
wdt:P31
wd:Q13442814
p:P921
wds:Q33570512-96F19DBC-F02D-4842-A457-F531C36044E4 wds:Q33570512-E1FE84AB-A516-41D4-AEBF-9591553417A2 wds:Q33570512-17ABA2B2-3DD7-4704-8D0E-101F3ED0D77C wds:Q33570512-4078AAD2-3F03-4610-B0C0-7DB9F13F1E43 wds:Q33570512-2B93E1AD-96AE-4A31-95AE-F266A0910767 wds:Q33570512-2C2E873D-A081-44A3-BBB3-E69F48D9EE67 wds:Q33570512-36BDAB05-C3F2-41D2-BAD7-83059D914220
wdt:P921
wd:Q412415 wd:Q420296 wd:Q180507 wd:Q1783924 wd:Q18554836 wd:Q18966654 wd:Q108565205
p:P698
wds:Q33570512-FA591C9A-B44D-4662-AF46-CD919D222315
wdtn:P698
n10:20066159
wdt:P698
20066159
p:P1433
wds:Q33570512-D9783473-7C60-49B4-A8A9-6D79F3785AC8
wdt:P1433
wd:Q26853876
p:P478
wds:Q33570512-66C7DBBC-46AE-4F60-89A4-5DE60847CFB1
wdt:P478
2009
p:P356
wds:Q33570512-350075E7-9C6C-4D50-B8AA-ED6972DEBB5C
wdtn:P356
n7:305908
wdt:P356
10.1155/2009/305908
p:P275
wds:Q33570512-D3905B87-8A34-4348-8CC2-D6093AF5BB5D
p:P6216
wds:Q33570512-E5ADF806-DC95-4886-9179-8B6E49B5DFCD
wdt:P275
wd:Q14947546
wdt:P6216
wd:Q50423863
p:P5875
wds:Q33570512-504424A1-DFEB-4132-966A-DA04C14299A2
wdt:P5875
40908686
p:P932
wds:Q33570512-95E36745-4EBA-4A2B-8CED-AA46C73B06F1
wdt:P932
2801452